

Frontal variant of Аlzheimer's disease
https://doi.org/10.30629/2658-7947-2024-29-6-56-63
Abstract
Alzheimer’s disease (AD) is a chronic neurodegenerative disease, that is the most common cause of dementia. Late on-set AD is usually associated with the classic picture of short-term memory deficits, while early onset AD demonstrates atypical symptoms. The frontal variant is the rarest non-amnestic AD phenotype, which associated with selective neurodegeneration in frontal control networks, which is confirmed by the presence of biomarkers of amyloid pathology. The clinical picture includes a wide variety of symptoms, including disinhibition, apathy, compulsive behavior and executive dysfunction, which often leads to difficulties in making a differential diagnosis with the behavioral variant of frontotemporal dementia) and, as a result, underestimation of the true prevalence of AD. The article provides a brief review of modern literature and a description of two clinical cases of the frontal variant of AD, confirmed by the study of cerebrospinal fluid biomarkers.
About the Authors
K. V. NevzorovaRussian Federation
Moscow
Yu. A. Shpilyukova
Russian Federation
Moscow
N. Yu. Abramycheva
Russian Federation
Moscow
A. A. Shabalina
Russian Federation
Moscow
E. Yu. Fedotova
Russian Federation
Moscow
S. N. Illarioshkin
Russian Federation
Moscow
References
1. Dubois B., Feldman H.H., Jacova C., Hampel H., Molinuevo J.L., Blennow K., DeKosky S.T., Gauthier S., Selkoe D., Bateman R., Cappa S., Crutch S., Engelborghs S., Frisoni G.B., Fox N.C., Galasko D., Habert M.O., Jicha G.A., Nordberg A., Pasquier F., Rabinovici G., Robert P., Rowe C., Salloway S., Sarazin M., Epelbaum S., de Souza L.C., Vellas B., Visser P.J., Schneider L., Stern Y., Scheltens P., Cummings J.L. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014 Jun;13(6):614–29. https://doi.org/10.1016/S1474-4422(14)70090-0
2. Lokshina A.B., Grishina D.A., Obukhova A.V. Early-onset Alzheimer’s disease. Nevrologiya, neiropsikhiatriya, psikhosomatika (Neurology, Neuropsychiatry, Psychosomatics). 2022;14(2):110–116. https://doi.org/10.14412/2074-2711-2022-2-110-116
3. Dubois B., Villain N., Frisoni G.B., Rabinovici G.D., Sabbagh M., Cappa S., Bejanin A., Bombois S., Epelbaum S., Teichmann M., Habert M.O., Nordberg A., Blennow K., Galasko D., Stern Y., Rowe C.C., Salloway S., Schneider L.S., Cummings J.L., Feldman H.H. Clinical diagnosis of Alzheimer’s disease: recommendations of the International Working Group. Lancet Neurol. 2021 Jun;20(6):484–496. https://doi.org/10.1016/S1474-4422(21)00066-1
4. Johnson J.K., Head E., Kim R., Starr A., Cotman C.W. Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol. 1999;56(10):1233–9. https://doi.org/10.1001/archneur.56.10.1233. PMID: 10520939.
5. Lehingue E., Gueniat J., Jourdaa S., Hardouin J.B., Pallardy A., Courtemanche H., Rocher L., Etcharry-Bouyx F., Auriacombe S., Mollion H., Formaglio M., Rouaud O., Bretonnière C., Thomas-Antérion C., Boutoleau-Bretonnière C. Improving the Diagnosis of the Frontal Variant of Alzheimer’s Disease with the DAPHNE Scale. J Alzheimers Dis. 2021;79(4):1735–1745. https://doi.org/10.3233/JAD-201088
6. Li C.H., Fan S.P., Chen T.F., Chiu M.J., Yen R.F., Lin C.H. Frontal variant of Alzheimer’s disease with asymmetric presentation mimicking frontotemporal dementia: Case report and literature review. Brain Behav. 2020 Mar;10(3):e01548. https://doi.org/10.1002/brb3.1548 .
7. Ossenkoppele R., Pijnenburg Y.A., Perry D.C., Cohn-Sheehy B.I., Scheltens N.M., Vogel J.W., Kramer J.H., van der Vlies A.E., La Joie R., Rosen H.J., van der Flier W.M., Grinberg L.T., Rozemuller A.J., Huang E.J., van Berckel B.N., Miller B.L., Barkhof F., Jagust W.J., Scheltens P., Seeley W.W., Rabinovici G.D. The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features. Brain. 2015 Sep;138(Pt 9):2732–49. https://doi.org/10.1093/brain/awv191
8. Mendez M.F., Karve S.J., Tassniyom K., Teng E., Shapira J.S. Clinicopathologic differences among patients with behavioral variant frontotemporal dementia. Neurology. 2013 Feb 5;80(6):561–8. https://doi.org/10.1212/WNL.0b013e3182815547
9. Ossenkoppele R., Singleton E.H., Groot C., Dijkstra A.A., Eikelboom W.S., Seeley W.W., Miller B., Laforce R.J., Scheltens P., Papma J.M., Rabinovici G.D., Pijnenburg Y.A.L. Research Criteria for the Behavioral Variant of Alzheimer Disease: A Systematic Review and Meta-analysis. JAMA Neurol. 2022 Jan 1;79(1):48–60. https://doi.org/10.1001/jamaneurol.2021.4417
10. Graff-Radford J., Yong K.X.X., Apostolova L.G., Bouwman F.H., Carrillo M., Dickerson B.C., Rabinovici G.D., Schott J.M., Jones D.T., Murray M.E. New insights into atypical Alzheimer’s disease in the era of biomarkers. Lancet Neurol. 2021 Mar;20(3):222–234. https://doi.org/10.1016/S1474-4422(20)30440-3
11. Polsinelli A.J., Apostolova L.G. Atypical Alzheimer Disease Variants. Continuum (Minneap Minn). 2022 Jun 1;28(3):676–701. https://doi.org/10.1212/CON.0000000000001082
12. Caviness J.N. Myoclonus and neurodegenerative disease — what’s in a name? Parkinsonism & Related Disorders, 2003; 9(4):185–192, https://doi.org/10.1016/S1353-8020(02)00054-8
13. Sasaki S. High prevalence of parkinsonism in patients with MCI or mild Alzheimer’s disease. Alzheimers Dement. 2018 Dec;14(12):1615–1622, https://doi.org/10.1016/j.jalz.2018.06.3054
14. Ossenkoppele R., Pijnenburg Y.A., Perry D.C., Cohn-Sheehy B.I., Scheltens N.M., Vogel J.W., Kramer J.H., van der Vlies A.E., La Joie R., Rosen H.J., van der Flier W.M., Grinberg L.T., Rozemuller A.J., Huang E.J., van Berckel B.N., Miller B.L., Barkhof F., Jagust W.J., Scheltens P., Seeley W.W., Rabinovici G.D. The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features. Brain. 2015 Sep;138(Pt 9):2732–49. https://doi.org/10.1093/brain/awv191
15. Bergeron D., Sellami L., Poulin S., Verret L., Bouchard R.W., Laforce R.Jr. The Behavioral/Dysexecutive Variant of Alzheimer’s Disease: A Case Series with Clinical, Neuropsychological, and FDG-PET Characterization. Dement Geriatr Cogn Disord. 2020;49(5):518–525. https://doi.org/10.1159/000511210
16. Bussè C., Zorzi G., Pettenuzzo I., Mozzetta S., Cagnin A. Episodic Memory in Amnestic Behavioral Frontotemporal Dementia and Alzheimer’s Disease. J Alzheimers Dis Rep. 2023 Jun 12;7(1):605–612. https://doi.org/10.3233/ADR-230015
17. Whitwell J.L., Jack C.R.Jr, Przybelski S.A., Parisi J.E., Senjem M.L., Boeve B.F., Knopman D.S., Petersen R.C., Dickson D.W., Josephs K.A. Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis. Neurobiol Aging. 2011 Sep;32(9):1531–41. https://doi.org/10.1016/j.neurobiolaging.2009.10.012
18. Cai H., Ning S., Li W., Li X., Xiao S., Sun L. Patient with frontal-variant syndrome in early-onset Alzheimer’s disease. Gen Psychiatr. 2020 Mar 17;33(2):e100173. https://doi.org/10.1136/gpsych-2019-100173
19. Shpilyukova Yu.A., Fedotova E.Yu., Abramycheva N.Yu., Illarioshkin S.N. Frequency of common genetic forms of frontotemporal dementia in a Russian cohort of patients. Medical Genetics. 2020;19(4):30–32. (In Russ.) https://doi.org/10.25557/2073-7998.2020.04.30-32
20. Rascovsky K., Hodges J.R., Knopman D., Mendez M.F., Kramer J.H., Neuhaus J., van Swieten J.C., Seelaar H., Dopper E.G., Onyike C.U., Hillis A.E., Josephs K.A., Boeve B.F., Kertesz A., Seeley W.W., Rankin K.P., Johnson J.K., Gorno-Tempini M.L., Rosen H., Prioleau-Latham C.E., Lee A., Kipps C.M., Lillo P., Piguet O., Rohrer J.D., Rossor M.N., Warren J.D., Fox N.C., Galasko D., Salmon D.P., Black S.E., Mesulam M., Weintraub S., Dickerson B.C., Diehl-Schmid J., Pasquier F., Deramecourt V., Lebert F., Pijnenburg Y., Chow T.W., Manes F., Grafman J., Cappa S.F., Freedman M., Grossman M., Miller B.L. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(9):2456–77. https://doi.org/10.1093/brain/awr179
21. Pasquier F., Leys D., Weerts J.G., Mounier-Vehier F., Barkhof F., Scheltens P. Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol. 1996;36(5):268–72. https://doi.org/10.1159/000117270
22. Scheltens P., Leys D., Barkhof F., Huglo D., Weinstein H.C., Vermersch P., Kuiper M., Steinling M., Wolters E.C., Valk J. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967–72. https://doi.org/10.1136/jnnp.55.10.967
23. Koedam E.L., Lehmann M., van der Flier W.M., Scheltens P., Pijnenburg Y.A., Fox N., Barkhof F., Wattjes M.P. Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol. 2011;21(12):2618–25. https://doi.org/10.1007/s00330-011-2205-4
24. Karanth S., Nelson P.T., Katsumata Y., Kryscio R.J., Schmitt F.A., Fardo D.W., Cykowski M.D., Jicha G.A., Van Eldik L.J., Abner E.L. Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults. JAMA Neurol. 2020;1;77(10):1299–1307. https://doi.org/10.1001/jamaneurol.2020.1741
25. Xiao X., Yuan Z., Guo L., Liao X., Zhou Y., Zhang W., Zhou L., Wang X., Liu X., Liu H., Wang J., Li J., Shen L., Jiao B. The role of frontotemporal dementia associated genes in patients with Alzheimer’s disease. Neurobiol Aging. 2021;107:153–158. https://doi.org/10.1016/j.neurobiolaging.2021.05.016
Review
For citations:
Nevzorova K.V., Shpilyukova Yu.A., Abramycheva N.Yu., Shabalina A.A., Fedotova E.Yu., Illarioshkin S.N. Frontal variant of Аlzheimer's disease. Russian neurological journal. 2024;29(6):56-63. (In Russ.) https://doi.org/10.30629/2658-7947-2024-29-6-56-63